Detalhe da pesquisa
1.
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
N Engl J Med
; 386(4): 316-326, 2022 01 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35081280
2.
Assessing the Performance of a Nutrition Knowledge Questionnaire With a Low Socioeconomic Status Population Using Rasch Analysis.
Health Promot Pract
; : 15248399231222463, 2024 Jan 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38243796
3.
Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial.
Ann Rheum Dis
; 82(3): 331-343, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36600185
4.
Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance.
Ann Rheum Dis
; 82(1): 119-129, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36137735
5.
Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial.
Ann Rheum Dis
; 81(11): 1491-1503, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35922124
6.
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. Reply.
N Engl J Med
; 386(18): 1768, 2022 05 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35507493
7.
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data.
Ann Rheum Dis
; 79(11): 1400-1413, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32759265
8.
Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan study.
Clin Exp Rheumatol
; 38(5): 848-857, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-31858963
9.
Barriers to Healthcare Seeking and Provision Among African American Adults in the Rural Mississippi Delta Region: Community and Provider Perspectives.
J Community Health
; 44(4): 636-645, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30661152
10.
Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme.
Ann Rheum Dis
; 82(4): 575-577, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36720582
11.
Age-based (<65 vs ≥65 years) incidence of infections and serious infections with tofacitinib versus biological DMARDs in rheumatoid arthritis clinical trials and the US Corrona RA registry.
Ann Rheum Dis
; 80(1): 134-136, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33046447
12.
Commentary: The Broader Context of Long-Term Care Ethics.
Camb Q Healthc Ethics
; 25(3): 554-6, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27348841
13.
Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis.
N Engl J Med
; 367(6): 495-507, 2012 Aug 09.
Artigo
Inglês
| MEDLINE | ID: mdl-22873530
14.
A randomized trial using motivational interviewing for maintenance of blood pressure improvements in a community-engaged lifestyle intervention: HUB city steps.
Health Educ Res
; 30(6): 910-22, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26590242
15.
Psychosocial constructs and postintervention changes in physical activity and dietary outcomes in a lifestyle intervention, HUB City Steps, 2010.
Prev Chronic Dis
; 12: E79, 2015 May 21.
Artigo
Inglês
| MEDLINE | ID: mdl-25996987
16.
Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study.
Ann Rheum Dis
; 73(1): 124-31, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23482473
17.
Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study.
Arthritis Rheum
; 65(3): 559-70, 2013 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-23348607
18.
Improvements in blood pressure among undiagnosed hypertensive participants in a community-based lifestyle intervention, Mississippi, 2010.
Prev Chronic Dis
; 11: E53, 2014 Apr 04.
Artigo
Inglês
| MEDLINE | ID: mdl-24698531
19.
Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study.
RMD Open
; 10(2)2024 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38609322
20.
Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk-Enriched Rheumatoid Arthritis Patients.
Arthritis Rheumatol
; 2024 Mar 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38481002